Skip Main Navigation
Page Content

Save This Event

Event Saved

Meet With...Illumina Accelerator and Illumina Ventures

JLABS Bay Area

Tuesday, April 10, 2018 from 10:30 AM to 1:00 PM (PDT)

Meet With...Illumina Accelerator and Illumina Ventures

Ticket Information

Ticket Type Sales End Price Fee Quantity
General Public Apr 8, 2018 $25.00 $3.45
Student/Academic Apr 8, 2018 $15.00 $2.89
Volunteer Mar 15, 2018 Free $0.00
At the door - Presentation & Lunch Only Not Started $35.00 $4.01

Share Meet With...Illumina Accelerator and Illumina Ventures

Event Details

Program Overview:
The purpose of the Meet with… Series events at JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners such as big pharma or other investment corporations, through one-on-one meetings.

On April 10th, the Head of Illumina Accelerator, Amanda Cashin, the Director of Investments at Illumina Ventures, and Wouter Meuleman will give an overview presentation about each group's key areas of interest including the types of early-stage companies they look for. Following the presentation, you'll have the opportunity to introduce yourself to Amanda and Wouter during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with Illumina, Inc., Illumina Accelerator (seed-stage), or Illumina Ventures (Series A-stage) will be scheduled, providing an intimate forum to discuss your company.

Some areas of interest include:

  • Genomics Research and Tools
  • Therapeutics Companies and Discovery Platforms (e.g., Oncology)
  • Reproductive Health
  • Agrigenomics
  • Applied Genomics
  • Complex Diseases
  • Microbial Genmoics and Microbiome
  • Informatics, Genomics Analysis

Illumina Accelerator is the world's first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. It provides select startups with seed investment, business guidance, access to Illumina's sequencing systems and reagents, and fully operational lab space in the San Francisco Bay Area during each six-month funding cycle. For more information, visit http://www.illumina.com/accelerator.

Illumina Ventures is a life sciences VC fund with a strong emphasis on genomics and a partnership with Illumina. The $230M fund invests primarily in Series A tools, diagnostics, and therapeutics companies with a focus on early-stage, disruptive technologies and platforms. For more information, visit http://www.illuminaventures.com.

Illumina, Inc., is looking for potential partnerships with companies that are advancing the field of genomics and pioneering new applications in healthcare, agriculture, environmental science, and personal wellness. Their goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. For more information, visit http://www.illumina.com.


Speakers:
Amanda Cashin, Ph.D. | Head of Illumina Accelerator, Illumina read bio»
Wouter Meuleman, Ph.D. | Director of Investments, Illumina Ventures read bio»

Agenda:

10:30am | Registration & Networking
11:00am | Company Presentation and Q&A
11:45am | Lunch & Networking
12:45-5:00pm | One-on-one Meetings*

*Companies must have applied ahead of time and be approved for a one-on-one meeting. Application period ends March, 12, 2018. Apply Here.

 

Representative:

Amanda Cashin, Ph.D. | Head of Illumina Accelerator, Illumina
Amanda Cashin, Ph.D. is Co-Founder and Head of Illumina Accelerator, a leading company creation engine and investment vehicle focused on building genomics-driven startups. Founded in Fall 2014 in San Francisco, Illumina Accelerator is investing in emerging startups, advancing breakthrough applications in genomics, including applications in therapeutics, women's health, cancer diagnostics, consumer nutrition, agriculture, synthetic biology, and skin microbiome.

Previously, Amanda was Senior Vice President of Alexandria Venture Investments/Alexandria Real Estate Equities, Inc. In her role, she helped lead Alexandria Venture Investments, which has over $250 million in capital deployed and committed to breakthrough life science and technology companies and leading venture capital funds. Amanda also led a team of life science professionals with strong science and business expertise responsible for industry research, company analysis, business development, and thought leadership limitations to help position Alexandria at the forefront of the industry.


She earned a Ph.D. in Chemical Biology from the California Institute of Technology and graduated summa cum laude with a Bachelor's degree in Physical Organic Chemistry from the University of Colorado, Boulder. Her scientific expertise and peer-reviewed publications are in the fields of biochemistry, organic chemistry, physical chemistry, pharmacology, electrophysiology, and neuroscience.
Connect with Amanda: Connect on LinkedIn

Wouter Meuleman, Ph.D. | Director of Investments, Illumina Ventures
Wouter is Director of Investments at San Francisco-based Illumina Ventures. Prior to Illumina Ventures, Wouter worked at Illumina, Inc. in various roles throughout the organization including R&D, Product Development, and Corporate Development. A physical chemist by training, he began his career in life sciences as first hire for Oxford University spin-out Oxamer, a company founded in 2003 by Prof. Sir Edwin Southern, where he led the development a benchtop DNA microarray fabrication platform. Following the company's incorporation into Oxford Gene Technology in 2005, he continued working alongside Prof. Southern leading R&D programs in areas such as single cell gene expression analysis and novel applications for DNA microarrays. He obtained his undergraduate and Master's degree in Chemistry from the University of Ghent, Belgium; a PhD in Chemical Engineering from the University of Newcastle, U.K; and an MBA from the University of Cambridge, U.K..
Connect with Wouter: Connect on LinkedIn


Fees:
Presentation
$25 | General Public
$35 | Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until 12:30pm on April 10th (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period will close on March 12, 2018. Your application will be reviewed and you will be notified of acceptance by March 23, 2018. Acceptance of one-on-one meeting is not guaranteed as all applications must be approved


About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.


Venue:
JLABS @ SSF
329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It



Have questions about Meet With...Illumina Accelerator and Illumina Ventures? Contact JLABS Bay Area

Save This Event

Event Saved

When & Where


Johnson & Johnson Innovation, JLABS
329 Oyster Point Blvd
3rd Floor
South San Francisco, CA

Tuesday, April 10, 2018 from 10:30 AM to 1:00 PM (PDT)


  Add to my calendar

Organizer

JLABS Bay Area

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

  Contact the Organizer
Meet With...Illumina Accelerator and Illumina Ventures
Things to do in South San Francisco, CA Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.